Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study)

The effects of galantamine (GAL) on quality of life (QoL) and cognitive speed, as well its effects combined with nimodipine (NIM) in Alzheimer disease (AD) with cerebrovascular disease (mixed dementia), have not been explored. Method : Double-blind, placebo-controlled, multicenter Brazilian trial,...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Paulo Caramelli, Jerson Laks, André Luis Fernandes Palmini, Ricardo Nitrini, Márcia Lorena Fagundes Chaves, Orestes Vicente Forlenza, Francisco de Assis Carvalho do Vale, Maira Tonidandel Barbosa, Cássio Machado de Campos Bottino, João Carlos Machado, Helenice Charchat-Fichman, Fabio Lorea Lawson
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Thieme Revinter Publicações 2014-06-01
Σειρά:	Arquivos de Neuro-Psiquiatria
Θέματα:	doença de Alzheimer desordens cerebrovasculares galantamina nimodipina
Διαθέσιμο Online:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014000600411&lng=en&tlng=en
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!